Truvaga™ Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market Expansion

April 30, 2024

https://www.globenewswire.com/news-release/2024/04/30/2872157/0/en/Truvaga-Plus-Demonstrates-Health-Benefits-in-Latest-Consumer-Study-Paving-the-Way-for-Market-Expansion.html

ROCKAWAY, N.J., April 30, 2024 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the results of its most recent Truvaga Plus consumer study conducted earlier this year. Based on a 30-day in-home use test by an independent third-party research firm, Truvaga Plus helped its users improve sleep, focus, stress, energy, and mood.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.